Terms: = Liver cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
12 results:
1. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study.
Shao G; Fan Z; Qiu W; Lv G
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16489-16499. PubMed ID: 37712961
[TBL] [Abstract] [Full Text] [Related]
3. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
[TBL] [Abstract] [Full Text] [Related]
4. Pancreaticoduodenectomy for a primary duodenal capicua transcriptional repressor (cic) -rearranged sarcoma with severe bleeding: a case report.
Aoki Y; Oshiro H; Yoshida A; Morishima K; Miki A; Sasanuma H; Sakuma Y; Lefor AK; Sata N
BMC Gastroenterol; 2020 Apr; 20(1):105. PubMed ID: 32293288
[TBL] [Abstract] [Full Text] [Related]
5. Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.
Hashiba T; Yamashita T; Okada H; Nio K; Hayashi T; Asahina Y; Hayashi T; Terashima T; Iida N; Takatori H; Shimakami T; Kawaguchi K; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Takamura H; Ohta T; Honda M; Kaneko S
Cell Mol Gastroenterol Hepatol; 2020; 10(2):269-285. PubMed ID: 32169577
[TBL] [Abstract] [Full Text] [Related]
6. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
[TBL] [Abstract] [Full Text] [Related]
7. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
Lu AQ; Lv B; Qiu F; Wang XY; Cao XH
Oncol Rep; 2017 Apr; 37(4):2071-2078. PubMed ID: 28350139
[TBL] [Abstract] [Full Text] [Related]
8. Primary cic-DUX4 round cell sarcoma of the kidney: A treatment-refractory tumor with poor outcome.
Bergerat S; Barthelemy P; Mouracade P; Lang H; Saussine C; Lindner V; Jacqmin D
Pathol Res Pract; 2017 Feb; 213(2):154-160. PubMed ID: 27919577
[TBL] [Abstract] [Full Text] [Related]
9. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
Rowehl RA; Burke S; Bialkowska AB; Pettet DW; Rowehl L; Li E; Antoniou E; Zhang Y; Bergamaschi R; Shroyer KR; Ojima I; Botchkina GI
PLoS One; 2014; 9(6):e99091. PubMed ID: 24921652
[TBL] [Abstract] [Full Text] [Related]
11. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
Int J Exp Pathol; 2011 Apr; 92(2):97-105. PubMed ID: 21070402
[TBL] [Abstract] [Full Text] [Related]
12. Protein A immunoadsorption in the treatment of malignant disease.
Messerschmidt GL; Henry DH; Snyder HW; Bertram J; Mittelman A; Ainsworth S; Fiore J; Viola MV; Louie J; Ambinder E
J Clin Oncol; 1988 Feb; 6(2):203-12. PubMed ID: 3276821
[TBL] [Abstract] [Full Text] [Related]
